article thumbnail

HSV Offers Promising Target for Preventive, Therapeutic Vaccines

Pharmacy Times

Vaccination provides an opportunity to prevent and treat herpes simplex virus infection.

Vaccines 127
article thumbnail

Delaying, Skipping, and Altering Vaccine Schedules: Addressing Selective Vaccination

Pharmacy Times

Pharmacists are poised to address selective vaccination and counsel patients contemplating delaying, skipping, or seeking an alternate vaccine schedule.

Vaccines 103
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

UK, Moderna formalise 10-year vaccines alliance

Pharma Phorum

Construction will start early next year of a new manufacturing centre in the UK with the capacity to produce 250 million vaccine doses per year, the centrepiece of a 10-year alliance between the government and US biotech Moderna.

article thumbnail

Promising RSV Vaccine Candidate Raises Hopes

Pharmacy Times

Pharmacists should educate patients about managing respiratory syncytial virus and let them know they may soon be able to get vaccinated.

Vaccines 121
article thumbnail

Stay Up-to-Date on COVID-19 Vaccine, Boosters

Pharmacy Times

Recommendations vary based on age, first vaccination received, and time since the last dose.

Vaccines 114
article thumbnail

Defining SARS-CoV-2 Bivalent Vaccines and Optimizing Protection Through Vaccination

Pharmacy Times

Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc; review what encompasses a bivalent vaccine and give their perspective on how to communicate the role of the vaccine in optimizing protection for patients.

article thumbnail

Vaccination Advocation Amid Misinformation

Pharmacy Times

Pharmacists discuss the impacts of inaccuracy on vaccine hesitancy and offer communication strategies for conversations with patients.

article thumbnail

First Indian intranasal COVID-19 vaccine about to launch

Pharmafile

Indian biotech company Bharat Biotech plans to launch its new intranasal COVID-19 vaccine iNCOVACC on the 26 January 2023 ‒ the vaccine is the first of its kind to be developed in India.

article thumbnail

Falling demand sees J&J scale back COVID-19 vaccine

Pharma Phorum

With demand for its COVID-19 vaccine decreasing, Johnson & Johnson (J&J) has begun scaling back production of the shots. Safety-wise, there was also the risk of a rare, but serious blood-clotting condition with the J&J vaccine that was a concern for some.

article thumbnail

BMS settles lawsuit with two fired employees who refused COVID vaccines

Fierce Pharma

BMS settles lawsuit with two fired employees who refused COVID vaccines kdunleavy Thu, 01/26/2023 - 14:30

Vaccines 100
article thumbnail

Multi- Year Global Vaccine Monitoring Project?

Fuld

A leading manufacturer of multiple infectious disease vaccines used Fuld & Company’s competitive monitoring services to gain a clear view of the evolving competitive landscape. ? The post Multi- Year Global Vaccine Monitoring Project? Background and Challenge.

article thumbnail

mRNA can deliver universal flu vaccine, say US researchers

Pharma Phorum

Scientists in the US say they have developed an mRNA-based vaccine that encompasses all 20 known subtypes of influenza that could form the basis of a future universal jab. The goals of the programme are also similar to those in COVID vaccine development.

article thumbnail

Vaccine Surpluses Drive Acrimonious European Debates

PharmExec

Member states air concerns over excess supplies of COVID vaccines.

article thumbnail

FDA starts speedy review of Takeda’s dengue vaccine

Pharma Phorum

The US regulator has started a priority, six-month review of Takeda’s dengue fever vaccine TAK-003 – tipped as a potential blockbuster product – making a decision likely in the first half of 2023. Takeda said last year that the vaccine could reach up to $1.6

article thumbnail

COVID-19 Booster Vaccination Protection Rates

Pharmacy Times

Jacinda Abdul-Mutakabbir, PharmD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; and Madeline King, PharmD, BCIDP, examine the efficacy and real-world implications of the COVID-19 booster shot in terms of vaccination protection rates.

Vaccines 103
article thumbnail

Vaccines Offer Protection Against Cold and Cough Symptoms

Pharmacy Times

Pharmacists play a vital role in administering these and educating patients about COVID-19, influenza, pneumococcal, and Tdap vaccinations.

Vaccines 109
article thumbnail

WuXi Vaccines to Debut New Vaccines Facility in China

Pharmaceutical Commerce

Plant will be CDMO’s first standalone GMP and vaccine development manufacturing site in the country.

article thumbnail

Impact of SARS-CoV-2 Subvariants on Vaccination

Pharmacy Times

Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, leads a discussion on the challenges subvariants of SARS-CoV-2 present in terms of vaccination and approaching optimal communication to the public surrounding vaccination.

article thumbnail

Higher Incidence of Myocarditis, Pericarditis Found After COVID-19 Vaccination

Pharmacy Times

Despite evidence of a higher risk of myocarditis or pericarditis with COVID-19 vaccination, immunization should still be recommended because the benefits likely outweigh the harms, study shows.

article thumbnail

Moderna now in the crosshairs of Sens. Warren, Welch over price tag for COVID vaccine

Fierce Pharma

Warren, Welch over price tag for COVID vaccine kdunleavy Wed, 01/25/2023 - 13:16Moderna now in the crosshairs of Sens.

article thumbnail

More vaccinated than unvaccinated died from COVID-19 in August: analysis

Fierce Healthcare

More vaccinated than unvaccinated died from COVID-19 in August: analysis. fdiamond. Mon, 11/28/2022 - 16:34

Vaccines 114
article thumbnail

How Pfizer Delivered the COVID-19 Vaccine in Record Time

PharmExec

Michael Ku, VP of global clinical supply at Pfizer, shares insights for the c-suite as well as reveals behind-the-scenes insight into Pfizer’s ability to deliver a COVID-19 vaccine swiftly.

article thumbnail

First needle-free COVID-19 vaccine patch

European Pharmaceutical Review

Vaxxas, a biotechnology company has announced the start of its Phase I clinical trial of a needle-free COVID-19 vaccine, delivered via a high-density microarray patch (HD-MAP), giving potential coverage of all major SARS-CoV-2 variants. Research data on the innovative COVID-19 vaccine patch.

article thumbnail

Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox

Pharmacy Times

Protect patients by evaluating VIGIV concentration and avoiding tearing of metal flange on vaccine vial.

article thumbnail

Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Shows Positive Early Trial Results

Pharmacy Times

Research showed the Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (Pfizer-BioNTech) increases neutralizing antibody response against multiple variants of Omicron.

Vaccines 132
article thumbnail

Senators blast Pfizer's proposed COVID vaccine price hike as 'profiteering'

Fierce Pharma

Senators blast Pfizer's proposed COVID vaccine price hike as 'profiteering'. fkansteiner. Wed, 12/14/2022 - 09:00

article thumbnail

Pfizer bivalent COVID-19 vaccine starts rollout

Pharma Phorum

The NHS is moving to the next phase of its SARS-CoV-2 vaccination programme, following health secretary Steve Barclay’s acceptance of advice from the Joint Committee on Vaccination and Immunisation (JCVI) to go ahead with rollout of Pfizer’s bivalent 30mg booster shot this week.

article thumbnail

Dengue Vaccine: What Pharmacists Need to Know

Pharmacy Times

The FDA approved the first vaccine for dengue disease in May 2019.

FDA 112
article thumbnail

Digital innovation drives vaccine development

Pharma Phorum

It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they need – especially with digital innovation driving new vaccine development. The importance of vaccine awareness and access.

article thumbnail

AstraZeneca’s intranasal COVID vaccine fails first clinical test

Pharma Phorum

An intranasal formulation of AstraZeneca’s widely-used COVID-19 vaccine Vaxzevria has failed at the first hurdle, after results from a phase 1 trial found it was unable to stimulate a strong immune response to the virus.

article thumbnail

Moderna’s HIV vaccine prepped for trials in Africa

Pharma Phorum

Moderna has joined forces with non-profit organisation IAVI on a third phase 1 trial of its candidate HIV vaccine in Africa, where the burden of the virus is still being keenly felt. They will be followed for six months to gauge the safety and immunogenicity of the vaccine.

Vaccines 114
article thumbnail

FDA Approves Vaccine to Prevent Whooping Cough in Newborns by Vaccinating Mothers at Third Trimester

Pharmacy Times

The vaccine prevents whooping cough in infants younger than 2 months. It can be safely administered to mothers who are in their third trimester.

Vaccines 121
article thumbnail

Pfizer’s COVID-19 vaccine under FDA’s examination following new research into adverse side effects

Pharmafile

The FDA, along with Taiwanese medical institutions, have been evaluating Pfizer’s mRNA COVID-19 vaccine, questioning the CDC’s omission of known severe “adverse events of special interest” (AESIs) which appeared in post-vaccination studies.

article thumbnail

Prosecutor confirms probe into Europe's COVID-19 vaccine purchasing

Fierce Pharma

Prosecutor confirms probe into Europe's COVID-19 vaccine purchasing. zbecker. Mon, 10/17/2022 - 15:37

Vaccines 111
article thumbnail

FDA advisors vote to standardize COVID vaccines as bivalent, stump for more data

Fierce Pharma

FDA advisors vote to standardize COVID vaccines as bivalent, stump for more data kdunleavy Fri, 01/27/2023 - 10:01

article thumbnail

Combination Flu, COVID-19, RSV mRNA Vaccine Could Change Immunizations Landscape

Pharmacy Times

Francesca Ceddia, MD, senior vice president of respiratory vaccines at Moderna, said the company is in early stages of development for a combined mRNA vaccine for influenza, COVID-19, and RSV.

article thumbnail

Merck and Moderna’s mRNA cancer vaccine aces its first efficacy trial

Pharma Phorum

The mRNA technology that was deployed so effectively in vaccines against COVID-19 has now been found to offer similar promise against cancer, according to Merck & Co and Moderna. The post Merck and Moderna’s mRNA cancer vaccine aces its first efficacy trial appeared first on.

article thumbnail

Takeda gets first approval for its dengue vaccine

Pharma Phorum

Japan’s Takeda has secured its first regulatory approval – in Indonesia – for its dengue fever vaccine TAK-003, which has been tipped as a potential blockbuster product. Qdenga is also the first of the company’s vaccine products to be marketed outside Japan.

article thumbnail

Pharmacists Play Pivotal Role in Flu Vaccines

Pharmacy Times

Key responsibilities include providing recommendations, administering vaccinations, disseminating evidence-based advice, reducing spread of influenza in communities.

Vaccines 103
article thumbnail

Study Finds New Insights in Young Adults Who Develop Myocarditis After COVID-19 Vaccination

Pharmacy Times

The risk of severe COVID-19 continues to outweigh the rare risk of post-vaccination myocarditis.

Vaccines 103
article thumbnail

Cancer vaccines: providing the edge in oncology

Pharma Phorum

In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector. One area that is gathering increasing levels of interest is the development of cancer vaccines.

Vaccines 104
article thumbnail

Johnson & Johnson scale back COVID-19 vaccination production

Pharmafile

US-based Johnson & Johnson (J&J) have begun scaling back production of their COVID-19 vaccine due to demand falling over the past few months. As part of this, they’ve started terminating manufacturing agreements with companies who helped them produce the vaccine, such as Catalent and Sanofi. read more. Manufacturing and Production

article thumbnail

Cancer Vaccine May be Effective for Melanoma Patients

Pharmacy Times

A researcher suggests that novel immune modulating cancer therapies like cancer vaccines can be more effective and safer alternative to previous cancer immunotherapies.